News & Events | NuVasive

NuVasive’s Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement

March 16, 2021

NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies

February 24, 2021

NuVasive Acquires Simplify Medical

February 8, 2021

NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area

News

Filter Content

Refine

May 5, 2020

NuVasive Expands Advanced Materials Science™ Implant Portfolio to Additional Thoracolumbar Procedures

May 4, 2020

NuVasive to Participate in BofA Securities 2020 Healthcare Conference

April 14, 2020

NuVasive Provides Business Update Related to COVID-19

March 10, 2020

Randomized Controlled Trial Results Published in Spine Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion

March 2, 2020

NuVasive to Participate at Spine Summit 2020

February 27, 2020

NuVasive to Participate in Cowen 40th Annual Healthcare Conference

February 26, 2020

NuVasive, Inc. Announces Pricing Of Offering Of $450 Million Of 0.375% Convertible Senior Notes Due 2025

February 26, 2020

NuVasive, Inc. Announces Proposed Offering Of $450 Million Of Convertible Senior Notes Due 2025

February 20, 2020

NuVasive Announces Fourth Quarter and Full Year 2019 Financial Results

« Previous
1
2
3
4
5
6
7
8
9
…
29
Next »

Upcoming Events

The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your healthcare professional. We do not practice medicine or provide medical services or advice as a part of this website. You should always talk to your healthcare professional for diagnosis and treatment.